Related Experiment Video

Updated: May 9, 2025

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
10:28

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue

Published on: July 17, 2018

11.7K

Adipokine Profiles and Their Association with Body Composition and Disease Activity in Pediatric Crohn's Disease

Ramit Magen-Rimon1,2, Michal Cohen3,4, Irit Rosen5

  • 1Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel. ramit.magen@technion.ac.il.

Digestive Diseases and Sciences
|April 29, 2025
PubMed

Insights

Pediatric Crohn's disease (CD) patients with active disease show higher levels of adiponectin and resistin. These inflammatory markers are linked to disease activity, not just body fat, suggesting a role in CD progression.

Area of Science:

  • Gastroenterology and Immunology
  • Pediatric Inflammatory Bowel Disease Research
  • Adipose Tissue Biology

Background:

  • Emerging evidence links visceral fat, including "creeping fat," to inflammatory bowel diseases (IBD), particularly Crohn's disease (CD).
  • Understanding the relationship between body composition, adipokines, and disease activity is crucial for pediatric CD management.

Purpose of the Study:

  • To investigate the association between body composition, adipocytokine profiles, and disease activity in pediatric patients with Crohn's disease.
  • To differentiate the roles of specific adipokines in active versus quiescent CD.

Main Methods:

  • Recruited pediatric patients (6-18 years) with active and quiescent CD, plus age-matched healthy controls.
  • Assessed body composition using bio-impedance analysis.
  • Measured adipocytokine levels (adiponectin, resistin, leptin) via ELISA-multiplex assays.

Main Results:

  • Active CD patients had significantly higher adiponectin and resistin levels than controls and those in remission, even after adjusting for body composition.
  • Leptin levels correlated with body composition but not disease activity.
  • Patients with active CD exhibited a higher percentage of body fat and total body fat.

Conclusions:

  • Adipocytokine profiles, specifically elevated adiponectin and resistin, are complexly associated with disease activity in pediatric Crohn's disease.
  • Further research is warranted to elucidate the mechanistic roles of adiponectin and resistin in CD pathogenesis.
Abstract

Keywords:
AdiponectinCrohn’s diseasePediatricResistin

More Related Videos

Identification and Dissection of Diverse Mouse Adipose Depots06:31

Identification and Dissection of Diverse Mouse Adipose Depots

Published on: July 11, 2019

39.7K
Isolation of Adipogenic and Fibro-Inflammatory Stromal Cell Subpopulations from Murine Intra-Abdominal Adipose Depots06:50

Isolation of Adipogenic and Fibro-Inflammatory Stromal Cell Subpopulations from Murine Intra-Abdominal Adipose Depots

Published on: August 16, 2020

2.5K

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
124
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
223
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
100
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
86